Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research
Key Information
Direct Link to Opportunity
https://cdn.pfizer.com/pfizercom/2023-02/GMG_2023-RD-US_ATTRAmyloidosisResearch.pdf?ohVihE5wk32nhy5lUh_c7Vmu6EaXkM7j=Application Deadline
Fund Type
Grant
Funding Agency
Pfizer
Agency Type
Non-Federal
Internal or External
External
Status of Applicants
See Opportunity Website
Discipline(s)
See Opportunity Website
Contact
See Opportunity Website